Breaking News Instant updates and real-time market news.

CXM

Sprinklr

$19.00 /

-0.34 (-1.76%)

05:27
07/19/21
07/19
05:27
07/19/21
05:27

Sprinklr initiated with an Overweight at Barclays

Barclays analyst Raimo Lenschow initiated coverage of Sprinklr with an Overweight rating and $26 price target. The analyst sees Sprinklr as a "pioneer" in the customer experience management space, saying its "expansive platform" consolidates up to 25 point solutions in the front office. With growth set to reaccelerate and a $49B market opportunity, the story is attractive, Lenschow tells investors in a research note.

  • 23

    Jun

CXM Sprinklr
$19.00 /

-0.34 (-1.76%)

07/19/21 Oppenheimer
Sprinklr initiated with an Outperform at Oppenheimer
07/19/21 JMP Securities
Sprinklr initiated with an Outperform at JMP Securities

TODAY'S FREE FLY STORIES

Recommendations
Americold Realty Trust price target lowered to $36 from $42 at Baird » 06:48
09/28/21
09/28
06:48
09/28/21
06:48
COLD

Americold Realty Trust

$29.75 /

-0.965 (-3.14%)

Baird analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COLD Americold Realty Trust
$29.75 /

-0.965 (-3.14%)

COLD Americold Realty Trust
$29.75 /

-0.965 (-3.14%)

09/23/21 RBC Capital
Americold Realty Trust price target lowered to $38 from $44 at RBC Capital
09/22/21 Truist
Americold Realty Trust price target lowered to $39 from $42 at Truist
09/22/21 Barclays
Americold Realty Trust price target lowered to $30 from $38 at Barclays
09/21/21 Truist
Americold Realty Trust price target lowered to $39 from $42 at Truist
COLD Americold Realty Trust
$29.75 /

-0.965 (-3.14%)

  • 14
    Oct
Hot Stocks
Gogo raises FY25 compound annual revenue growth target to 15% from at least 10% » 06:48
09/28/21
09/28
06:48
09/28/21
06:48
GOGO

Gogo

$12.21 /

-0.11 (-0.89%)

Sees FY25 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOGO Gogo
$12.21 /

-0.11 (-0.89%)

GOGO Gogo
$12.21 /

-0.11 (-0.89%)

08/05/21 Roth Capital
Gogo recent weakness a buying opportunity, says Roth Capital
07/22/21 Roth Capital
Roth Capital sees weakness in Gogo shares as buying opportunity
05/10/21 Cowen
Gogo price target raised to $15 from $14 at Cowen
04/22/21 William Blair
Gogo lowered annual interest expensive by 64%, says William Blair
GOGO Gogo
$12.21 /

-0.11 (-0.89%)

GOGO Gogo
$12.21 /

-0.11 (-0.89%)

GOGO Gogo
$12.21 /

-0.11 (-0.89%)

Hot Stocks
TopBuild to appoint Robert Kuhns as CFO after John Peterson's retirement » 06:47
09/28/21
09/28
06:47
09/28/21
06:47
BLD

TopBuild

$221.38 /

+2.21 (+1.01%)

TopBuild announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLD TopBuild
$221.38 /

+2.21 (+1.01%)

BLD TopBuild
$221.38 /

+2.21 (+1.01%)

09/10/21 JPMorgan
TopBuild price target raised to $264 from $246 at JPMorgan
09/09/21
Fly Intel: Top five analyst upgrades
09/09/21 Benchmark
TopBuild upgraded to Buy from Hold at Benchmark
08/04/21 BTIG
TopBuild price target raised to $271 from $257 at BTIG
BLD TopBuild
$221.38 /

+2.21 (+1.01%)

Hot Stocks
Pfizer, BioNTech submit data to FDA from trial of COVID-19 vaccine in children » 06:47
09/28/21
09/28
06:47
09/28/21
06:47
PFE

Pfizer

$43.55 /

-0.4 (-0.91%)

, BNTX

BioNTech

$307.09 /

-26.47 (-7.94%)

Pfizer (PFE) and BioNTech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$43.55 /

-0.4 (-0.91%)

BNTX BioNTech
$307.09 /

-26.47 (-7.94%)

PFE Pfizer
$43.55 /

-0.4 (-0.91%)

09/27/21 Barrington
Barrington says Somatrogon delay does not change Opko Health view
09/24/21 Piper Sandler
Piper confident in Opko's somatrogon approval despite BLA review delay
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
BNTX BioNTech
$307.09 /

-26.47 (-7.94%)

09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
08/20/21 Canaccord
BioNTech price target raised to $450 from $240 at Canaccord
PFE Pfizer
$43.55 /

-0.4 (-0.91%)

BNTX BioNTech
$307.09 /

-26.47 (-7.94%)

PFE Pfizer
$43.55 /

-0.4 (-0.91%)

BNTX BioNTech
$307.09 /

-26.47 (-7.94%)

PFE Pfizer
$43.55 /

-0.4 (-0.91%)

BNTX BioNTech
$307.09 /

-26.47 (-7.94%)

PFE Pfizer
$43.55 /

-0.4 (-0.91%)

Downgrade
Kraton downgraded to Hold from Buy at Loop Capital » 06:46
09/28/21
09/28
06:46
09/28/21
06:46
KRA

Kraton

$45.39 /

+3.78 (+9.08%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRA Kraton
$45.39 /

+3.78 (+9.08%)

KRA Kraton
$45.39 /

+3.78 (+9.08%)

06:44 Today Loop Capital
Kraton downgraded to Hold from Buy at Loop Capital
07/07/21 Stifel
Kraton bid of $50 per share 'reasonable max upside' expectation, says Stifel
06/15/21 Loop Capital
Kraton price target raised to $58 from $55 at Loop Capital
10/19/20 Truist
Truist raises price targets in select Chemicals names
KRA Kraton
$45.39 /

+3.78 (+9.08%)

KRA Kraton
$45.39 /

+3.78 (+9.08%)

KRA Kraton
$45.39 /

+3.78 (+9.08%)

KRA Kraton
$45.39 /

+3.78 (+9.08%)

Recommendations
Ashland price target lowered to $110 from $115 at Deutsche Bank » 06:45
09/28/21
09/28
06:45
09/28/21
06:45
ASH

Ashland

$89.52 /

-3.2 (-3.45%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASH Ashland
$89.52 /

-3.2 (-3.45%)

ASH Ashland
$89.52 /

-3.2 (-3.45%)

09/07/21 BMO Capital
Ashland price target raised to $113 from $107 at BMO Capital
09/01/21 Deutsche Bank
Ashland price target raised to $115 from $100 at Deutsche Bank
07/30/21 JPMorgan
Ashland upgraded to Neutral from Underweight at JPMorgan
06/17/21 Stifel
Ashland initiated with a Buy at Stifel
ASH Ashland
$89.52 /

-3.2 (-3.45%)

  • 17
    Nov
Recommendations
Griffon should react positively to strategic review news, says Baird » 06:45
09/28/21
09/28
06:45
09/28/21
06:45
GFF

Griffon

$24.51 /

+0.825 (+3.48%)

Baird analyst Timothy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GFF Griffon
$24.51 /

+0.825 (+3.48%)

GFF Griffon
$24.51 /

+0.825 (+3.48%)

06/01/21 Baird
Griffon an attractive value against expensive overall market, says Baird
12/09/20 Raymond James
Griffon initiated with an Outperform at Raymond James
11/13/20 Baird
Griffon weakness a buying opportunity, says Baird
11/11/20
Fly Intel: Top five analyst initiations
GFF Griffon
$24.51 /

+0.825 (+3.48%)

Hot Stocks
Agnico Eagle, Kirkland Lake Gold to combine in merger of equals » 06:44
09/28/21
09/28
06:44
09/28/21
06:44
AEM

Agnico Eagle

$50.54 /

+0.035 (+0.07%)

, KL

Kirkland Lake Gold

$43.90 /

+1.52 (+3.59%)

Agnico Eagle (AEM) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AEM Agnico Eagle
$50.54 /

+0.035 (+0.07%)

KL Kirkland Lake Gold
$43.90 /

+1.52 (+3.59%)

AEM Agnico Eagle
$50.54 /

+0.035 (+0.07%)

09/24/21 KeyBanc
Agnico Eagle initiated with a Sector Weight at KeyBanc
09/10/21 National Bank
Agnico Eagle downgraded to Sector Perform from Outperform at National Bank
07/16/21 National Bank
Agnico Eagle price target lowered to C$102 from C$108 at National Bank
07/08/21 Barclays
Agnico Eagle price target lowered to $67 from $69 at Barclays
KL Kirkland Lake Gold
$43.90 /

+1.52 (+3.59%)

09/10/21 National Bank
Kirkland Lake Gold price target lowered to C$58 from C$59 at National Bank
08/03/21 National Bank
Kirkland Lake Gold price target raised to C$59 from C$56 at National Bank
07/13/21 National Bank
Kirkland Lake Gold price target lowered to C$56 from C$57 at National Bank
05/20/21 National Bank
Kirkland Lake Gold price target raised to C$57 from C$52 at National Bank
AEM Agnico Eagle
$50.54 /

+0.035 (+0.07%)

AEM Agnico Eagle
$50.54 /

+0.035 (+0.07%)

KL Kirkland Lake Gold
$43.90 /

+1.52 (+3.59%)

Upgrade
Okta upgraded to Overweight from Equal Weight at Morgan Stanley » 06:44
09/28/21
09/28
06:44
09/28/21
06:44
OKTA

Okta

$241.52 /

-11.84 (-4.67%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OKTA Okta
$241.52 /

-11.84 (-4.67%)

OKTA Okta
$241.52 /

-11.84 (-4.67%)

06:42 Today Morgan Stanley
Okta upgraded to Overweight at Morgan Stanley on improving demand environment
06:09 Today Morgan Stanley
Okta upgraded to Overweight from Equal Weight at Morgan Stanley
09/03/21 Deutsche Bank
Okta results unlikely to quash investor debate, says Deutsche Bank
09/02/21
Fly Intel: Top five analyst upgrades
OKTA Okta
$241.52 /

-11.84 (-4.67%)

OKTA Okta
$241.52 /

-11.84 (-4.67%)

OKTA Okta
$241.52 /

-11.84 (-4.67%)

OKTA Okta
$241.52 /

-11.84 (-4.67%)

Hot Stocks
Archer co-CEOs Goldstein, Adcock buy 100K shares each » 06:44
09/28/21
09/28
06:44
09/28/21
06:44
ACHR

Archer

$9.05 /

-0.225 (-2.43%)

In regulatory filings,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACHR Archer
$9.05 /

-0.225 (-2.43%)

ACHR Archer
$9.05 /

-0.225 (-2.43%)

09/01/21 Benchmark
Atlas Crest Investment initiated with a Buy at Benchmark
ACHR Archer
$9.05 /

-0.225 (-2.43%)

ACHR Archer
$9.05 /

-0.225 (-2.43%)

Downgrade
Kraton downgraded to Hold from Buy at Loop Capital » 06:44
09/28/21
09/28
06:44
09/28/21
06:44
KRA

Kraton

$45.39 /

+3.78 (+9.08%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRA Kraton
$45.39 /

+3.78 (+9.08%)

KRA Kraton
$45.39 /

+3.78 (+9.08%)

07/07/21 Stifel
Kraton bid of $50 per share 'reasonable max upside' expectation, says Stifel
06/15/21 Loop Capital
Kraton price target raised to $58 from $55 at Loop Capital
10/19/20 Truist
Truist raises price targets in select Chemicals names
10/16/20 Loop Capital
Kraton price target raised to $45 from $29 at Loop Capital
KRA Kraton
$45.39 /

+3.78 (+9.08%)

KRA Kraton
$45.39 /

+3.78 (+9.08%)

KRA Kraton
$45.39 /

+3.78 (+9.08%)

KRA Kraton
$45.39 /

+3.78 (+9.08%)

Downgrade
Fangdd Network downgraded to Underweight from Equal Weight at Morgan Stanley » 06:43
09/28/21
09/28
06:43
09/28/21
06:43
DUO

Fangdd Network

$1.12 /

-0.085 (-7.05%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DUO Fangdd Network
$1.12 /

-0.085 (-7.05%)

12/30/20
Fangdd Network initiated with a Buy at TF International
DUO Fangdd Network
$1.12 /

-0.085 (-7.05%)

Recommendations
PSEG price target lowered to $66 from $67 at Mizuho » 06:42
09/28/21
09/28
06:42
09/28/21
06:42
PEG

PSEG

$61.22 /

+0.52 (+0.86%)

Mizuho analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PEG PSEG
$61.22 /

+0.52 (+0.86%)

PEG PSEG
$61.22 /

+0.52 (+0.86%)

05/25/21 Barclays
PSEG price target raised to $67 from $62 at Barclays
05/24/21 Seaport Global
PSEG upgraded to Buy from Neutral at Seaport Global
04/29/21 Mizuho
PSEG upgraded to Buy from Neutral at Mizuho
04/14/21 KeyBanc
PSEG price target raised to $65 from $60 at KeyBanc
PEG PSEG
$61.22 /

+0.52 (+0.86%)

Periodicals
Big tech companies are buying properties during Covid-19, WSJ reports » 06:42
09/28/21
09/28
06:42
09/28/21
06:42
GOOG

Alphabet

$2,830.94 /

-22.76 (-0.80%)

, GOOGL

Alphabet Class A

$2,821.88 /

-21.53 (-0.76%)

, AMZN

Amazon.com

$3,406.70 /

-20.28 (-0.59%)

, FB

Facebook

$353.62 /

+0.485 (+0.14%)

Big technology companies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOOG Alphabet
$2,830.94 /

-22.76 (-0.80%)

GOOGL Alphabet Class A
$2,821.88 /

-21.53 (-0.76%)

AMZN Amazon.com
$3,406.70 /

-20.28 (-0.59%)

FB Facebook
$353.62 /

+0.485 (+0.14%)

GOOG Alphabet
$2,830.94 /

-22.76 (-0.80%)

09/27/21 BofA
Roku selloff overdone as streaming lead remains, says BofA
09/17/21 Jefferies
Alphabet price target raised to $3,325 from $3,150 at Jefferies
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Goldman Sachs
Alphabet Class A initiated with a Buy at Goldman Sachs
GOOGL Alphabet Class A
$2,821.88 /

-21.53 (-0.76%)

09/27/21 BofA
Roku selloff overdone as streaming lead remains, says BofA
09/17/21 Jefferies
Alphabet price target raised to $3,325 from $3,150 at Jefferies
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Goldman Sachs
Alphabet Class A initiated with a Buy at Goldman Sachs
AMZN Amazon.com
$3,406.70 /

-20.28 (-0.59%)

09/27/21 BofA
Roku selloff overdone as streaming lead remains, says BofA
09/27/21 Morgan Stanley
Morgan Stanley cuts Amazon target to $4,100 on rising wage pressure
09/24/21 Morgan Stanley
Vtex upgraded to Overweight from Equal Weight at Morgan Stanley
09/24/21 Oppenheimer
Opco downgrades Cloudflare amid competition from Amazon, Microsoft
FB Facebook
$353.62 /

+0.485 (+0.14%)

09/24/21 BTIG
Etsy price target raised to $238 from $215 at BTIG
09/22/21 Morgan Stanley
Facebook blog post not signal of near-term ad revenue risk, says Morgan Stanley
09/22/21 BMO Capital
Facebook guidance unchanged, not much new on technical side, says BMO Capital
09/22/21 Baird
Facebook IDFA update largely consistent with industry checks, says Baird
GOOG Alphabet
$2,830.94 /

-22.76 (-0.80%)

GOOGL Alphabet Class A
$2,821.88 /

-21.53 (-0.76%)

AMZN Amazon.com
$3,406.70 /

-20.28 (-0.59%)

FB Facebook
$353.62 /

+0.485 (+0.14%)

GOOG Alphabet
$2,830.94 /

-22.76 (-0.80%)

GOOGL Alphabet Class A
$2,821.88 /

-21.53 (-0.76%)

AMZN Amazon.com
$3,406.70 /

-20.28 (-0.59%)

FB Facebook
$353.62 /

+0.485 (+0.14%)

GOOG Alphabet
$2,830.94 /

-22.76 (-0.80%)

GOOGL Alphabet Class A
$2,821.88 /

-21.53 (-0.76%)

AMZN Amazon.com
$3,406.70 /

-20.28 (-0.59%)

FB Facebook
$353.62 /

+0.485 (+0.14%)

GOOGL Alphabet Class A
$2,821.88 /

-21.53 (-0.76%)

AMZN Amazon.com
$3,406.70 /

-20.28 (-0.59%)

FB Facebook
$353.62 /

+0.485 (+0.14%)

Downgrade
Microchip downgraded to Equal Weight on valuation at Wells Fargo » 06:42
09/28/21
09/28
06:42
09/28/21
06:42
MCHP

Microchip

$166.02 /

+0.55 (+0.33%)

Wells Fargo analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCHP Microchip
$166.02 /

+0.55 (+0.33%)

MCHP Microchip
$166.02 /

+0.55 (+0.33%)

05:27 Today Wells Fargo
Microchip downgraded to Equal Weight from Overweight at Wells Fargo
09/20/21 Longbow
Texas Instruments downgraded to Neutral from Buy at Longbow
09/17/21 BofA
Microchip price target raised to $185 from $170 at BofA
08/04/21 BMO Capital
Microchip price target raised to $175 from $165 at BMO Capital
MCHP Microchip
$166.02 /

+0.55 (+0.33%)

MCHP Microchip
$166.02 /

+0.55 (+0.33%)

MCHP Microchip
$166.02 /

+0.55 (+0.33%)

Hot Stocks
FDA grants Priority Review to ViiV Healthcare's NDA for cabotegravir long-acting » 06:41
09/28/21
09/28
06:41
09/28/21
06:41
GSK

GlaxoSmithKline

$38.49 /

+0.1 (+0.26%)

, PFE

Pfizer

$43.55 /

-0.4 (-0.91%)

ViiV Healthcare, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$38.49 /

+0.1 (+0.26%)

PFE Pfizer
$43.55 /

-0.4 (-0.91%)

GSK GlaxoSmithKline
$38.49 /

+0.1 (+0.26%)

09/20/21 UBS
GlaxoSmithKline price target lowered to 1,460 GBp from 1,540 GBp at UBS
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
PFE Pfizer
$43.55 /

-0.4 (-0.91%)

09/27/21 Barrington
Barrington says Somatrogon delay does not change Opko Health view
09/24/21 Piper Sandler
Piper confident in Opko's somatrogon approval despite BLA review delay
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
GSK GlaxoSmithKline
$38.49 /

+0.1 (+0.26%)

PFE Pfizer
$43.55 /

-0.4 (-0.91%)

GSK GlaxoSmithKline
$38.49 /

+0.1 (+0.26%)

PFE Pfizer
$43.55 /

-0.4 (-0.91%)

GSK GlaxoSmithKline
$38.49 /

+0.1 (+0.26%)

PFE Pfizer
$43.55 /

-0.4 (-0.91%)

GSK GlaxoSmithKline
$38.49 /

+0.1 (+0.26%)

PFE Pfizer
$43.55 /

-0.4 (-0.91%)

Periodicals
BHP shareholders urged by Glass Lewis to vote against climate plan, FT reports » 06:41
09/28/21
09/28
06:41
09/28/21
06:41
BHP

BHP Group

$55.07 /

+0.535 (+0.98%)

BHP is preparing to face…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHP BHP Group
$55.07 /

+0.535 (+0.98%)

BHP BHP Group
$55.07 /

+0.535 (+0.98%)

09/21/21 BofA
BHP Group downgraded to Neutral from Buy at BofA
09/20/21 Berenberg
BHP Group downgraded to Hold from Buy at Berenberg
09/14/21 Barclays
BHP Group downgraded to Equal Weight from Overweight at Barclays
08/18/21 RBC Capital
BHP Group price target lowered to 2,300 GBp from 2,400 GBp at RBC Capital
BHP BHP Group
$55.07 /

+0.535 (+0.98%)

BHP BHP Group
$55.07 /

+0.535 (+0.98%)

BHP BHP Group
$55.07 /

+0.535 (+0.98%)

Recommendations
Verisk Analytics price target raised to $235 from $203 at RBC Capital » 06:40
09/28/21
09/28
06:40
09/28/21
06:40
VRSK

Verisk Analytics

$203.69 /

-4.37 (-2.10%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRSK Verisk Analytics
$203.69 /

-4.37 (-2.10%)

VRSK Verisk Analytics
$203.69 /

-4.37 (-2.10%)

08/09/21 Raymond James
Verisk Analytics price target raised to $210 from $190 at Raymond James
08/05/21 BMO Capital
Verisk Analytics price target raised to $195 from $182 at BMO Capital
07/21/21 Morgan Stanley
Verisk Analytics at good point to add to positions, says Morgan Stanley
07/07/21 RBC Capital
Verisk Analytics assumed with an Outperform at RBC Capital
VRSK Verisk Analytics
$203.69 /

-4.37 (-2.10%)

Recommendations
Motorola Solutions price target raised to $267 from $247 at Barclays » 06:40
09/28/21
09/28
06:40
09/28/21
06:40
MSI

Motorola Solutions

$238.85 /

-1.93 (-0.80%)

Barclays analyst Tim Long…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSI Motorola Solutions
$238.85 /

-1.93 (-0.80%)

MSI Motorola Solutions
$238.85 /

-1.93 (-0.80%)

08/06/21 MKM Partners
Motorola Solutions price target raised to $260 from $222 at MKM Partners
07/15/21 Northcoast
Motorola Solutions price target raised to $244 from $215 at Northcoast
07/09/21 Jefferies
UK Airwave probe of Motorola Solutions a 'red herring' says Jefferies
07/06/21 Jefferies
Motorola Solutions price target raised to $260 from $230 at Jefferies
MSI Motorola Solutions
$238.85 /

-1.93 (-0.80%)

Downgrade
Wells Fargo downgraded to Equal Weight at Morgan Stanley on asset cap drag » 06:39
09/28/21
09/28
06:39
09/28/21
06:39
WFC

Wells Fargo

$47.55 /

-0.37 (-0.77%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WFC Wells Fargo
$47.55 /

-0.37 (-0.77%)

WFC Wells Fargo
$47.55 /

-0.37 (-0.77%)

05:12 Today Morgan Stanley
Wells Fargo downgraded to Equal Weight from Overweight at Morgan Stanley
09/23/21 JPMorgan
Wells Fargo asset cap will be around for longer, says JPMorgan
09/16/21 JPMorgan
JPMorgan does not expect Wells Fargo to be broken up
09/10/21 JPMorgan
Wells Fargo OCC fine 'moderate and manageable,' says JPMorgan
WFC Wells Fargo
$47.55 /

-0.37 (-0.77%)

WFC Wells Fargo
$47.55 /

-0.37 (-0.77%)

WFC Wells Fargo
$47.55 /

-0.37 (-0.77%)

WFC Wells Fargo
$47.55 /

-0.37 (-0.77%)

Initiation
Intact Financial initiated with an Outperform at Credit Suisse » 06:39
09/28/21
09/28
06:39
09/28/21
06:39
IFCZF

Intact Financial

$133.78 /

-1.05 (-0.78%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IFCZF Intact Financial
$133.78 /

-1.05 (-0.78%)

07/30/21 Desjardins
Intact Financial price target raised to C$190 from C$185 at Desjardins
07/29/21 CIBC
Intact Financial price target raised to C$197 from C$188 at CIBC
07/29/21 RBC Capital
Intact Financial price target raised to C$197 from C$196 at RBC Capital
07/29/21 BMO Capital
Intact Financial price target raised to C$200 from C$190 at BMO Capital
Hot Stocks
Eli Lilly to lower list price of Insulin Lispro Injection by additional 40% » 06:38
09/28/21
09/28
06:38
09/28/21
06:38
LLY

Eli Lilly

$226.40 /

-5.33 (-2.30%)

Eli Lilly will lower the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$226.40 /

-5.33 (-2.30%)

LLY Eli Lilly
$226.40 /

-5.33 (-2.30%)

09/24/21 JPMorgan
Eli Lilly remains best positioned growth story in pharma, says JPMorgan
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
LLY Eli Lilly
$226.40 /

-5.33 (-2.30%)

LLY Eli Lilly
$226.40 /

-5.33 (-2.30%)

LLY Eli Lilly
$226.40 /

-5.33 (-2.30%)

LLY Eli Lilly
$226.40 /

-5.33 (-2.30%)

Hot Stocks
Naked Brand Group chairman says found 'disruptive opportunity' in clean energy » 06:37
09/28/21
09/28
06:37
09/28/21
06:37
NAKD

Naked Brand Group

/

+

In an update to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NAKD Naked Brand Group
/

+

NAKD Naked Brand Group
/

+

Recommendations
Progyny price target raised to $80 from $72 at Barclays » 06:37
09/28/21
09/28
06:37
09/28/21
06:37
PGNY

Progyny

$60.89 /

-2.56 (-4.03%)

Barclays analyst Sarah…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PGNY Progyny
$60.89 /

-2.56 (-4.03%)

PGNY Progyny
$60.89 /

-2.56 (-4.03%)

08/25/21 Barclays
Progyny price target raised to $72 from $64 at Barclays
08/12/21 Barclays
Progyny initiated with an Overweight at Barclays
06/02/21 Guggenheim
Progyny downgraded to Neutral from Buy at Guggenheim
04/29/21 JPMorgan
Progyny resumed with an Overweight at JPMorgan
PGNY Progyny
$60.89 /

-2.56 (-4.03%)

  • 13
    Oct
PGNY Progyny
$60.89 /

-2.56 (-4.03%)

Hot Stocks
Allete to sell portion of stake in NTEC to Basin Electric Power Coop for $20M » 06:37
09/28/21
09/28
06:37
09/28/21
06:37
ALE

Allete

$59.77 /

+0.34 (+0.57%)

ALLETE announced it is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALE Allete
$59.77 /

+0.34 (+0.57%)

ALE Allete
$59.77 /

+0.34 (+0.57%)

03/02/21 Mizuho
Allete price target raised to $62 from $55 at Mizuho
01/20/21 Guggenheim
Allete downgraded to Neutral from Buy at Guggenheim
ALE Allete
$59.77 /

+0.34 (+0.57%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.